Researchers in Germany have found success in treating patients with depression by implanting pacemakers in their brains.
Researchers from the Bonn University Hospital implanted pacemaker electrodes into the medial forebrain bundle in the brains of patients suffering from major depression. In six out of seven patients, symptoms improved both considerably and rapidly.
Depression
Depression is one of the most common mental disorders affecting approximately 340 million people in the world. No one is immune from depression - it occurs in people of all social classes, all countries and all cultural settings.
Advertisement
The method of Deep Brain Stimulation had already been tested on various structures within the brain, but with clearly lesser effect.
The results of this new study have now been published in the international journal Biological Psychiatry.
"The effects, as well as the speed of the response has so far not been achieved with any other method," says Prof. Dr. Thomas E. Schlapfer from the Bonn University Hospital Department of Psychiatry and Psychotherapy.
Source: IANS
"The effects, as well as the speed of the response has so far not been achieved with any other method," says Prof. Dr. Thomas E. Schlapfer from the Bonn University Hospital Department of Psychiatry and Psychotherapy.
Source: IANS
Adolescent Depression
Adolescent depression is an ailment that occurs during the teenage characterized by persistent melancholy, disappointment and loss of self-esteem.
Advertisement
 Holistic Management for DepressionDepression is a common disorder and many worldwide suffer from depression. Early recognition of symptoms and signs of depression can help in taking a holistic approach to the management of depression. | Advertisement
|
Depression Symptom Evaluation
Depression occurs due to alterations in the levels of neurotransmitters in the brain.
Advertisement
Recommended Readings
Latest Research News
Cerebrospinal fluid (CSF) leaks are detected in approximately 1-3% of adults who have experienced a traumatic brain injury.
The optogenetic activation of hippocampal astrocytes can be viewed as a novel therapeutic avenue for addressing Alzheimer's disease.
In Alzheimer's disease condition, the control and adjustment of ABCA7 levels in response to inflammation and the decrease in the availability of cholesterol.
Atopic dermatitis (AD) and inflammatory bowel disease (IBD) can lead to alterations in the microbiome, and disruptions in the skin and gut barrier.
Gaining insights into mortality risks among vitiligo patients will enhance patient counseling, healthcare monitoring, and overall patient management strategies.
